Close Menu

St. Jude

BioSkryb will now have an exclusive global license for clinical applications of primary template directed amplification technology.

St. Jude Children's Research Hospital researchers evaluated a microbial cell-free DNA sequencing test from infectious disease diagnostics firm Karius.

Right Patient Right Drug will use the PharmacoScan platform to perform preventive pharmacogenetic testing under St. Jude's PG4KDS program.